ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,881.63
-0.43%
Dow Jones
42,544.22
-0.07%
US Dollar vs MXN
20.8139
-0.26%
Brent Oil
73.855
-1.33%
Bitcoin
94,604.10
1.31%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Lifecore Biomedical Inc (LFCR) Cotización

Lifecore Biomedical Inc

Lifecore Biomedical Inc (LFCR)

NASDAQ
7.43
0.01
(0.13%)
Cerrado 01 Enero 3:00PM
Delayed by 15 minutes
7.43
0.00
(0.00%)
Fuera de horario: 5:56PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
7.43
Postura de Compra
7.43
Postura de Venta
7.79
Volume Operado de la Acción
786,372
7.28 Rango del Día 7.59
3.6793 Rango de 52 semanas 8.90
Capitalización de Mercado [m]
229.574M
Precio Anterior
7.42
Precio de Apertura
7.49
Hora
3
@
7.62
Última hora de negociación
Volumen financiero
US$ 5,830,805
Precio Promedio Ponderado
7.4148
Volumen promedio (3 m)
192,392
Acciones en circulación
30,898,255
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
19.11
Beneficio por acción (BPA)
0.39
turnover
128.26M
Beneficio neto
12.01M

Acerca de Lifecore Biomedical Inc

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hy... Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Mostrar más

Sector
Plastics,resins,elastomers
Industria
Plastics,resins,elastomers
Sitio web
www.lifecore.com
Sede
Wilmington, Delaware, USA
Fundado
-
Lifecore Biomedical Inc is listed in the Plastics,resins,elastomers sector of the NASDAQ with ticker LFCR. The last closing price for Lifecore Biomedical was US$7.42. Over the last year, Lifecore Biomedical shares have traded in a share price range of US$ 3.6793 to US$ 8.90.

Lifecore Biomedical currently has 30,898,255 shares in issue. The market capitalisation of Lifecore Biomedical is US$229.27 million. Lifecore Biomedical has a price to earnings ratio (PE ratio) of 19.11.

LFCR Últimas noticias

Más noticias

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

26 Diciembre 2024
Edgar (US Regulatory)

Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

CHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

19 Diciembre 2024
GlobeNewswire Inc.

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial Lifecore to Leverage Differentiated Capabilities and...

19 Diciembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

10 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Diciembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

26 Noviembre 2024
Edgar (US Regulatory)

Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall Financial Position Builds Upon Other Recent...

26 Noviembre 2024
GlobeNewswire Inc.

Lifecore Biomedical Hosts Virtual Investor Day

CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

21 Noviembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

21 Noviembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

20 Noviembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.34.207573632547.137.786.8952381227.45581717CS
4-0.13-1.719576719587.567.886.852179897.36642856CS
122.2543.43629343635.187.994.331923926.68835873CS
262.2242.61036468335.217.993.67932093485.66931143CS
521.2820.81300813016.158.93.67932099915.83663546CS
156-1.65-18.17180616749.0811.4551.523229755.87546292CS
260-1.65-18.17180616749.0811.4551.523229755.87546292CS

LFCR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Lifecore Biomedical?
El precio actual de las acciones de Lifecore Biomedical es US$ 7.43
¿Cuántas acciones de Lifecore Biomedical están en circulación?
Lifecore Biomedical tiene 30,898,255 acciones en circulación
¿Cuál es la capitalización de mercado de Lifecore Biomedical?
La capitalización de mercado de Lifecore Biomedical es USD 229.27M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Lifecore Biomedical?
Lifecore Biomedical ha negociado en un rango de US$ 3.6793 a US$ 8.90 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Lifecore Biomedical?
El ratio precio/beneficio de Lifecore Biomedical es 19.11
¿Cuál es el ratio de efectivo a ventas de Lifecore Biomedical?
El ratio de efectivo a ventas de Lifecore Biomedical es 1.79
¿Cuál es la moneda de reporte de Lifecore Biomedical?
Lifecore Biomedical presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Lifecore Biomedical?
El último ingresos anual de Lifecore Biomedical es USD 128.26M
¿Cuál es el último beneficio anual de Lifecore Biomedical?
El último beneficio anual de Lifecore Biomedical es USD 12.01M
¿Cuál es la dirección registrada de Lifecore Biomedical?
La dirección registrada de Lifecore Biomedical es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Lifecore Biomedical?
La dirección del sitio web de Lifecore Biomedical es www.lifecore.com
¿En qué sector industrial opera Lifecore Biomedical?
Lifecore Biomedical opera en el sector PLASTICS,RESINS,ELASTOMERS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BDMDBaird Medical Investment Holdings Ltd
US$ 7.6699
(630.47%)
89.74M
APMAptorum Group Ltd
US$ 2.799
(106.57%)
116.74M
COEPCoeptis Therapeutics Holdings Inc
US$ 5.44
(75.48%)
5.08M
VRMEVerifyMe Inc
US$ 1.332
(68.63%)
94.05M
VEEETwin Vee PowerCats Company
US$ 0.55
(53.59%)
5.62M
WATTEnergous Corporation
US$ 1.00
(-62.26%)
29.33M
SGMOSangamo Therapeutics Inc
US$ 1.02
(-56.41%)
44.56M
INTZIntrusion Inc
US$ 3.07
(-45.95%)
15.07M
KZIAKazia Therapeutics Ltd
US$ 1.78
(-42.58%)
708.99k
TOIIWOncology Institute Inc
US$ 0.0052
(-42.22%)
366.02k
SVMHSRIVARU Holding Ltd
US$ 0.0423
(26.65%)
794.74M
XTIAXTI Aerospace Inc
US$ 0.0422
(6.84%)
446.31M
EYENEyenovia Inc
US$ 0.1474
(30.10%)
412.83M
CRKNCrown Electrokinetics Corporation
US$ 0.146899
(5.91%)
402.05M
ONCOOnconetix Inc
US$ 0.6479
(48.26%)
270.47M

Discusión

Ver feed completo
crazy horse 0 crazy horse 0 4 minutos hace
Up to 5 Suspects Involved in New Orleans Attack

https://www.youtube.com/watch?v=JKDdBplkSd4
LVerstee LVerstee 6 minutos hace
You did not even read what I posted jumping on it like a dog I heat.

Maybe you should read again.

Also I know more about that account than you do smart guy.
ITUP
KILLAZILLA KILLAZILLA 6 minutos hace
LOLOLOLOL....Good one. You definitely got him on that one
WDLF
frenchbroad frenchbroad 6 minutos hace
You propose a company can use and sell Brilacidin and pay Ipix nothing?
It is you who lies.
IPIX
crazy horse 0 crazy horse 0 7 minutos hace
Calif or NY which one is worst


Footage of San Diego homeless internment camp

https://x.com/BenBergquam/status/1874560431844647026
RealDutch RealDutch 7 minutos hace
or struggles to get a bank account opened in normal fashion

They did in fact open the bank account at Citi. And it is not just any corporate bank account. It is a premium account that allows them to trade gold globally. But you wouldn't know, would you, because you are clueless about
ITUP
mascale mascale 7 minutos hace
Per google global: "The Balfour Project is considered to be located within a "Strategic prospectivity zone" in Tasmania, meaning the Tasmanian government identifies the area as having significant potential for mining exploration and development, making it a strategically important region for minera
HIRU
JTORENCE JTORENCE 8 minutos hace
ATLnsider This was a slam dunk for MHRA. Most likely approved it in a few weeks. Already being used /approved world wide. No comparison for the rigors that NWBO had to go thru.
NWBO
rich2 rich2 8 minutos hace
VERY HAPPY 2025 TO ALL NBRI LONGS an non -believing posters

IN 2025 I believe we will all see NBRI really come alive. Able to buy .0002 &.0003, now at .0008-.0009. I will not sell knowing what I own. The NEW CEO inherited A giant previous mess. Jared is one by one solving them all. Wh
NBRI
cowtown jay cowtown jay 8 minutos hace
I shared this post, for the first time, on Dr. John's website.

https://www.youtube.com/watch?v=pPvMy9-h8Ic

It is shown as a comment in his video titled "Distribution and toxicity."
ChannelTrader ChannelTrader 8 minutos hace
Good for him, a great Prez.
El Salvador Pres. ordered all Commie statues and monuments to be melted and instead used for equipment to help build roads

https://x.com/IanJaeger29/status/1874537861749555302
TenKay TenKay 8 minutos hace
What “deal” are you talking about at 30%???

The poster I was responding to was valuing SMX at $10 per share when the market was at $0.5-$0.6. That’s a 1700% premium! LMAO!
SMX
stockinspector stockinspector 9 minutos hace
I rolled my previous investment back into WDLF already,
Is it hard to put a bikini on a pig? You just have to ask nicely?
WDLF
LittleBirdin my Ear LittleBirdin my Ear 10 minutos hace
Definitely hope so !!!!!
RGTI
Lurker3 Lurker3 11 minutos hace
Why dont you look at your own country first before you critisize the inequality of another country.

I am sure that The Netherlands isnt paradise on earth.

Before ciritisizing an other country make sure that The Netherlands is perfect.
LWLG
YY1000 YY1000 11 minutos hace
As has been pointed out, when 953 was filed, PFE compound was already disclosed. Given this it was not unreasonable to file 953 as was done, rather than go to patent office and attempt to correct 048 (if that was even an option). If the PTO objected to broadening to include C1, the typo argument cou
ENTA PFE
janice shell janice shell 12 minutos hace
Awww...
MULN
georgie18 georgie18 14 minutos hace
That’s when I like to buy them…Long term chart sees $7 plus…imo …we shall see…🥳
copytele copytele 15 minutos hace
1 HOUR BEFORE THE BELL ~~~~~~~1 HOUR AFTER THE BELL / $18.50 [SEE THE CHART , THEY TEND TO REPEAT/AND DO A PATTERN DAILY]
RGTI
WooptdooU WooptdooU 16 minutos hace
Lebby deserves what is coming...eom
LWLG
AJH92 AJH92 16 minutos hace
$PSRU Overview - Updated January 1, 2025
------------------------------------------
$PSRU Portfolio of Companies / Partnerships

$PSRU is a multi-sector corporation leveraging innovation, asset-backed ventures and strategic partnerships [source: PR December 12, 2024]
MDCN PSRU
ironhammer ironhammer 16 minutos hace
I agree the next few weeks ,months will be revealing .So far Jared has followed through on what he has stated on the PRs . Which is something that could take months or years for some companies to follow through on . Its definitely not the case here he follows through on what he says .I to am concer
NBRI
WooptdooU WooptdooU 17 minutos hace
Worry about yourself pal...jackoff...
LWLG
TightCoil TightCoil 17 minutos hace
FNMA/FMCC

Oh, never mind
FMCC

Su Consulta Reciente

NASDAQ
LFCR
Lifecore Biomedical
BIT
NET
Net Insurance AOR
LATK
ADAXUSDT
ADAX
LATK
IVNTETH
IVNT Token
COIN
RFRUSD
Refereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados